Clinical Trials Browser

Phase 1 × Terminated × surufatinib × Clear all

NCT04427774 2021-07-20

A Study of Surufatinib Plus Sintilimab in Patients With Advanced Solid Tumor

Phase 1 Terminated

Other solid neoplasm

Advanced or Metastatic Solid Tumors